chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within minutes of receiving vaccine, eyes fluttered, skin color became pale, pt stated she felt ?funny?. Complained of lips tingling, cold packs applied to back of neck and forehead. Approximately 5 min later appeared to ?dry heave?, spit up clear mucus, small amount. Pt was eased to floor and legs raised on chair. B/P monitored, radial pulse remained even 72 BPM. C/o tingling L hand, intermittent. Pt took several attempts to sit up. Light headedness would return, pale, nausea with dry heave. After continued rest for approximately 20 min, color returned to face, tingling resolved, able to sit up, stand, walk, stating ?I feel better now?. Took sips of water throughout episode. Was to leave work accompanied by coworker. Advised not to drive. Going home; mother at home.
the inside top roof of the mouth went numb, and then the nose and kind of under the eyes, described as the bridge of the face, went numb; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (the inside top roof of the mouth went numb, and then the nose and kind of under the eyes, described as the bridge of the face, went numb) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PARACETAMOL (TYLENOL) and ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced HYPOAESTHESIA (the inside top roof of the mouth went numb, and then the nose and kind of under the eyes, described as the bridge of the face, went numb). At the time of the report, HYPOAESTHESIA (the inside top roof of the mouth went numb, and then the nose and kind of under the eyes, described as the bridge of the face, went numb) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No laboratory details were  provided. No treatment medications were reported.
Initial unsolicited report received from a pharmacist via other company (Pfizer) (Manufacturer Report Number: 2017111828) on 22-Mar-2017. This case involves a male patient (onset age not reported) who was vaccinated with a dose of TETANUS VACCINE AND TOXOID (batch number, expiration date, dose, dose in series, route and site of administration were not reported) on an unspecified date. Patient's relevant medical history and concomitant medications were not reported. On an unspecified date following vaccination (Latency unknown), the patient experienced allergy to tetanus vaccines and toxoid. Laboratory investigations and corrective treatment were not reported. The outcome of the event was not reported. List of documents held by sender: none.
Tiredness and fatigue the day after the vaccine, felt better the day after. Starting four to five days after the vaccine experienced dizziness and vertigo, dyspepsia and prolonged fatigue (sleeping 9+ hours). Has not resolved.
Since I?ve gotten the vaccine, I have not taken a solid poop.  All of my bowel movements have been watery diarrhea. My appetite has gone down immensely, and when I DO eat, I immediately have diarrhea afterwards.  I have chills followed by feeling overheated.
8/10/21 - toes, finger and lips  started tingling  8/15/21 - chest pain, tightness in chest, shortness of breath, tachycardia started tingly toes and fingers, burpy, uncomfortable leaning back sitting in a chair or sofa and very uncomfortable laying down to sleep, normally sleep on side and had to prop up on back to fall asleep. entire body feels shakey after waking up in the morning. pressure on front of throat.   8/24- Dr - doctor visit and EKG. Ekg was normal, referred me to cardiologist  8/31/21 - visit with Dr, Cardiologist, EKG was normal. Suggested heart monitor test.  9/14/21-9/19/21  Holter Heart Monitor - I have a 22 page report of results. normal sinus rhythm with 778 occurrences of sinus tachycardia in 5 days, max heart rate 191.  Contacted clinic to see if they could help me with my issues and they said they could not if it may be vaccine related. they said to report to the CDC.
12/5/2022  ADMINSTION ERROR - Men quad was order and bexero was given.  And pt. left the office but we need to bring her back to give correct vaccine.
Sharp pains in her right calf; shoulder started to hurt; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sharp pains in her right calf) and ARTHRALGIA (shoulder started to hurt) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017b21a) for COVID-19 vaccination.     No medical History reported by the reporter.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sharp pains in her right calf) and ARTHRALGIA (shoulder started to hurt). The patient was treated with MENTHOL, METHYL SALICYLATE (SALONPAS [MENTHOL;METHYL SALICYLATE]) for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sharp pains in her right calf) and ARTHRALGIA (shoulder started to hurt) had resolved.            No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Follow-up received outcome of event updated to Resolved and Patient declined further follow-up.
This spontaneous report was received from a Registered Nurse refers to twin 4 year old female patients vaccinated with (Oka/Merck) VARIVAX. On 20-JUN-2014, the patient was vaccinated with (Oka/Merck) VARIVAX, subcutaneous. This is the second dose in the series. On an 20-JUN-2014, the patient received VARIVAX that was exposed to a maximum of 17.2 Fahrenheit for cumulative 41.5 hours (supported). The outcome of receiving VARIVAVX that was exposed to a maximum of 17.2 Fahrenheit for cumulative 41.5 hours is unknown. Additional information is not expected. This case is linked to 1407USA009865 due to twin patients who were vaccinated on the same date 20-JUN-2014.
Immediately after receiving 3rd dose, she experienced burning in throat,torso,upper arm,chest,lower back; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (Immediately after receiving 3rd dose, she experienced burning in throat,torso,upper arm,chest,lower back) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 053E21A, 048A21A and 024M20A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and LORAZEPAM for an unknown indication.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Sep-2021, the patient experienced BURNING SENSATION (Immediately after receiving 3rd dose, she experienced burning in throat,torso,upper arm,chest,lower back). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for Adverse event, at an unspecified dose and frequency. At the time of the report, BURNING SENSATION (Immediately after receiving 3rd dose, she experienced burning in throat,torso,upper arm,chest,lower back) outcome was unknown.            Concomitant product included unspecified BP medications. Patient received her 1st dose on 12Feb2021, 2nd dose on 09Mar2021 and 3rd dose on 01Sep2021 on her right arm intramuscularly in deltoid muscle. Immediately after receiving 3rd dose, she experienced burning in Torso. Her throat was also burning. Her upper arm was burning. She was kept at site. After she went to home, since that time, she has been having burning sensation in chest, torso, upper arm, lower back and throat.
sore throat, cough, muscle aches   Tested positive for Covid 08/19/2021
CONSTANT NAUSEA AROUND 1 AM; SEVERE HEADACHE; DIZZINESS DESCRIBED AS VERTIGO (WORSENS WHEN HEAD MOVES); FEVER; This spontaneous report received from a consumer concerned a 48 year old male. The patient's height, and weight were not reported. The patient's past medical history included bilateral knee replacements, and concurrent conditions included bipolar disorder, non alcohol user, cigarette smoker, migraines, and type 2 diabetes. The patient had no known allergies or drug abuse/illicit drug use.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: unknown) dose was not reported, administered on left arm 03-APR-2021 at around 15:00 for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included paliperidone palmitate for bipolar disorder.  On 03-APR-2021, around 22:00, the patient experienced severe headache, dizziness described as vertigo (worsened when head moves) and fever around 100 degrees. On 04-APR-2021, around 1:00, the patient experienced constant nausea. Treatment medications (date unspecified) included: acetylsalicylic acid/caffeine/paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from severe headache, dizziness described as vertigo (worsens when head moves), constant nausea around 1 am, and fever. This report was non-serious.; Sender's Comments: V0: Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
Approximately 5 minutes after second vaccine (Menveo), patient stated "I can't see anything" from the Immunization Waiting room. Patient appeared to be pale, blinking rapidly, pupils were dilated, and she was diaphoretic. Registered nursing staff contacted to assist, and several doctors came in to evaluate patient. Patient had low blood pressure, running in the 60's/40's. Sent to ER via stretcher.
This initial spontaneous case was received on 10-Oct-2017, from other health professional, concerning a 09-year-old child. The patient's medical history and concomitant medications were not reported. On 08-Oct-2017, the patient was administered with FLUCELVAX QIV (dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch number: 195128, expiry date: Apr-2018). On the same day, the patient experienced injection site redness, pain and warm. The patient was treated with BENADRYL oral, applied ice and hydrocortisone cream. It was reported that, the events resolved after 2 days. The reporter assessed the event as non-serious. Follow-up received on 26-Oct-2017: The injection site reaction was reported as raised, red, hot, size of coke can. The patient applied hydrocortisone cream and the events resolved after 2 days. Narrative amended accordingly.
A report has been received from a Health Professional concerning a 6 month old, subject of unknown gender, who had been receiving Nasal FLUMIST Quadrivalent. FLUMIST Quadrivalent started on 30-OCT-2015. A six-month-old patient was administered 2 doses of FLUMIST Quadrivalent on OCT 30 and NOV 24, at their doctor's office. On November 13, the patient did return to the doctor's office for an upper respiratory tract infection. The outcome of the event of inadvertent administration to a 6-month-old is unknown and the patient recovered from the event of upper respiratory tract infection following FLUMIST administration on an unspecified date. The report was considered to be non-serious by the reporter. The reporter and company physician considered the events inadvertent administration to a 6-month-old and upper respiratory tract infection following FLUMIST administration to be unrelated to the suspect drug of FLUMIST Quadrivalent.
Little headache after the 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Little headache after the 1st dose) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination.     The patient's past medical history included Hypersensitivity reaction (NOS). Concurrent medical conditions included Diabetes mellitus and Drug allergy (long history of allergies to certain medication).    On 30-Apr-2021 at 5:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, the patient experienced HEADACHE (Little headache after the 1st dose). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. At the time of the report, HEADACHE (Little headache after the 1st dose) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       The patient reported taking many unspecified concomitant medications for unknown conditions. She reported a history of anaphylactic shock after the administration of an unspecified pneumonia vaccine.   This case was linked to MOD-2021-209026 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: Patient demographics updated. Relevant history added.
Mild headache starting about 3 hours after vaccination and lasting into the next day (about 17-24 hours post vaccination), treated with two doses of Advil. Severe diarrhea began the day after vaccination (3/21/21) at approx. 10pm with symptoms of bloating, heartburn, cramps, gas and soft stool that progressed to explosive watery diarrhea lasting until 11:30pm. On 3/22/21, I experienced a feeling of an unsettled stomach with some mild nausea, decreased appetite, and overall feeling of fatigue throughout the day with mild body aches, which was treated with 1 dose of Advil.
This spontaneous report as received from a pharmacist via a poison and drug center refers to a 73 year old male patient. No information regarding the patient's medical history or concurrent conditions was provided. On 08-OCT-2015, the patient was vaccinated with a single dose of ZOSTAVAX injection (lot# reported as L0000447, expiry date 08-MAR-2016; exact dose was not reported) subcutaneously in his right arm. There were no concomitant therapies reported. During the injection of ZOSTAVAX, the needle came loose and the pharmacist was only able to administer about a half of the dose to the patient. It was unknown if the patient was going to receive another dose of ZOSTAVAX. The reporter considered the events to be non-serious. Additional information has been requested.
High fever treated with cool cloth to forehead, lukewarm bath, ibuprofen infant drops.
This spontaneous report was received from a medical assistant referring to a 44 year old patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 26-MAY-2017, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 with lot # N003997 and expiration date 20-OCT-2018 (dose and route of administration were not reported) for prophylaxis. There was no adverse effect or product quality complaint reported. No excursion details had been determined at the time of the report. There was a data logger involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1708USA011654.
At 1:07pm  patient complained of her throat itching and feeling light headed.  Vitals taken every 5 minutes.  Patient initially declined IM Benadryl. At 1:21pm Benadryl 50 mg/mL was administered IM. Patient observed for one hour and recovered from feeling light headed and throat itching.  At 2:05pm, patient was alert and oriented x3 and walked out of clinic with a steady gait. Patient accompanied by her sister.
PT presents to the Hospital Emergency Department with complaints of chest pain that started a few hours prior to presentation to the emergency department. The chest pain is in the middle of his chest and radiates to his back.. He is a current everyday smoker. Chest x-ray showed no acute process. A CT angiogram of the chest did reveal pulmonary embolus in the segmental branch in the the medial right lower lobe. He also tested positive for COVID-19. He was started on a heparin drip  Patient was found to be hypokalemic on admission at 3.0, after 40 mEq potassium patient's potassium increased to 3.3. Additional labs reveal creatinine currently 1.4 from baseline 1.0.  Patient continued to do well with only complaint being cough associated with chest pain. Decision to discharge patient was made. Decision to place patient on Eliquis was made.
Patient ran a fever after vaccine of 100.  On 08/02/2011, patient began breaking out in a varicella rash on legs and arms.  Fever continued - 101.3. Rash continued to spread to torso, buttocks, feet, hands, face, and scalp on 08/03/2011.  Fever continued at 100.2. Patient presented with 100+ lesions.  Patient returned to doctor and was diagnosed with varicella.
MODERATE TO SEVERE, VARYING TIME AND INTENSITY, PERIPHERAL NEUROPATHY. SEVERE BILATERALLY FOR FEET, PINS AND NEEDLES AND BURNING. NUMBNESS PINS AND NEEDLES, CRAMPING IN CALVES. NUMBNESS TINGLING IN LUMBAR REGION AND DOWN RIGHT SCIATIC NERVE. NUMBNESS IN BOTH HANDS, TINGLING IN BOTH HANDS. TINGLING AND SIGNIFICANT ARTHRITIC PAIN IN SERVICAL SPINES. MODERATE TENSION (?) HEADACHE IN BACK OF NECK.  MINOR TO MODERATE DIZZINESS. AT TIMES, WOOZY, AT OTHER TIMES UNABLE TO STAND. BETTER WHEN LYING DOWN.  FATIGUE, CHILLS AND HOTFLASHES VARYING IN TIME AND INTENSITY. GENERALLY UNABLE TO DO ANYTHING SIGNIFICANT.
Patient was given Proquad SQ in the right thigh. Within a minute she complained about it itching and then the redness and swelling was noticed instantly by the medical assistant that gave the vaccine.
Side effects she got after receiving the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side effects she got after receiving the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects she got after receiving the vaccine). At the time of the report, VACCINATION COMPLICATION (Side effects she got after receiving the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided
Itchy skin all over.  No rash.   Started about 8 hours after injection.  Took diphenhydramine and it finally subsided enough to sleep.
no adverse reaction. unknown if patient received 0.2 ml of pediatric or adult pfizer.
He woke up with a diffuse rash on his arms, legs and trunk - red, raised lesions, no blisters. No tongue swelling, difficulty swallowing or breathing. No rash on his genitals or mouth. Took benadryl approx one hour ago. Denies dysphagia, denies SOB. Reports he has joint aches.
I woke up with pain in left shoulder and neck.  As the day went on noticed I had a knot that was red where I was injected in left arm. Pain shoots through shoulder and neck when I make certain movements and even sometimes when I take a deep breath. Over the course of the weekend, the not became more noticeable, red and warm to touch and had numbness and tingling in fingers on left hand.  The site of injection was even itchy with a burning sensation. It is now Monday and the pain does not seem to be getting better even thought the injection sight does not seem to be as irritated.
Pt. presented with 104 temperature. Erythematous and warm arm.  ID physician stated it was a "Type 4" reaction.  Patient was discharged the following day.  ID physician stated that because of rapid onset and progression he felt it was a reaction to the vaccine rather than "cellulitis".
I had blood work done in March 2023 and in April I saw the doctor because I was planning to have a knee replacement.  In one month's, time my liver enzymes had jumped from about 67 to 676.  I was sent for an ultrasound of the liver and they found cirrosis of the liver, non-alcoholic.
Patient is a 50 y.o. male patient with history of hypertension, diabetes mellitus type 2 that presented to Hospital with shortness of breath.   Acute hypoxic respiratory failure, possibly due to acute bronchitis COVID-19 virus infection Continue azithromycin and dexamethasone Oxygen saturation 93% on 2 L nasal cannula.   Covid-19 Virus Infection Date of onset of symptoms: 2 weeks Symptoms present on admission: cough, shortness of breath Date of covid positive test: 10/31/2022 Vaccination status: vaccinated Imaging: Chest x-ray showed increased bronchovascular lung markings.  No acute airspace disease.  CT scan showed no pulmonary embolism and small pleural effusion with atelectatic change possible inflammatory/pleuritic process Oxygen requirements on admission: 4 L per nasal cannula Current oxygen requirements: 2 L per nasal cannula Medical therapy: steroids Anticipated special isolation end date: 11/9/2022  Acute kidney injury BUN was 27 with a creatinine of 1.55 on admission. Appreciate nephrology consultation Creatinine is down to 1.32 today. Continue to monitor.  Diabetes mellitus type 2 Resume previous home regimen at discharge.  Hypertension Continue amlodipine, atenolol, clonidine.        Hyperlipidemia Continue statin  Hypothyroid Continue levothyroxine  Gastroesophageal reflux disease Continue PPI   Morbid obesity BMI 48.23
MMR #1 administered SQ R arm. Immediate local reaction->6 x 5 cm area of redness with minimal induration. No cough or wheezing.
Head to toe severe hives (urticaria) - taking Zyrtec 1x day, Benadryl 1x day and Cimetidine 2x day - already finished 5 days Prednisone. Also eating low histamine diet.
Pt states slight pain in right thumb/palm (pollicis muscle) at 10:06 am ( 14 min after administration).  Incident was reported to pharmacist and an ice pack was given to Pt and applied to right thumb/palm area. At 10:16 am Pt states the ice pack helped and she stated she feels fine to go home. Pt took ice pack and left facility with her sister and parents.  I advised Pt to call emergency response should any further reactions occur. Pt agreed to plan.
extremely long periods; This is a spontaneous report from a contactable consumer (patient).  This non-pregnant 41-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm on 18May2021 at 12:00 (Lot number ER8731) as single dose for COVID-19 immunisation. The patient had no COVID prior vaccination. The patient's medical history was none. The patient had no known allergies. No other vaccine in four weeks and no other medications in two weeks. The patient reported that her menstrual cycle was completely off, she normally was right on time and had not been. The patient was experiencing extremely long periods that are resulting in large clots. The event onset date was reported on "08Apr2021 at 12:00". The events did not result in emergency room visit and physician office visit. It was unknown if patient received treatment or not. The outcome of the events was not resolved.  COVID was not tested post vaccination.